Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Peter E. Boyd is See Remarks at Aquestive Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Sep 29, 2025, each linked to the official Form 4.
See Remarks
Disclosures on record
2
Companies involved
1
As of the latest filing on , Peter E. Boyd reported holding 278,323 shares of Aquestive Therapeutics (AQST), worth about $1.09M at the last close of $4 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aquestive Therapeutics AQST | 278,323 | 278K direct | $4 | $1.09M | Sep 26, 2025 |
Is this Peter E. Boyd’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Aquestive TherapeuticsAQST
2 disclosures · Sep 2025 · 2 sold
Sep 26, 2025Sold~$63Kdisclosed Sep 29
DetailsOfficial recordSep 5, 2025Sold~$80Kdisclosed Sep 8
DetailsOfficial recordPeter E. Boyd bought shares on the open market in 2018, 2019, 2020 and 2022, and has not bought since 2022. Sales in 1 of the 9 years since 2018.
Peter E. Boyd reported 5 open-market purchases and 2 sales since 2018; purchases in 4 different years, most recently 2022.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $143K2×2 trades |
| 2022 | $6.3K2×2 trades | — |
| 2020 | $3K1×1 trade | — |
| 2019 | $2.3K1×1 trade | — |
| 2018 | $2K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Sep 26, 2025, Peter E. Boyd reported holding 278,323 shares of Aquestive Therapeutics (AQST). At the last close of $4 on Nov 13, 2026, that is about $1.09M. This is the stake disclosed in filings, not a net worth.
Peter E. Boyd bought shares on the open market in 2018, 2019, 2020 and 2022, and has not bought since 2022. Sales in 1 of the 9 years since 2018.
In SEC filings since 2018: the latest open-market purchase is from 2022; the latest open-market sale is from 2025.
Aquestive Therapeutics (AQST), from 2018 to 2025: 5 purchases and 2 sales.
Peter E. Boyd reported 5 open-market purchases and 2 sales here, 2018 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
